North America Organ Transplant Diagnostics Market 2022-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Country: Trend Forecast and Growth Opportunity
- Report ID: 43051
- Date: Aug, 2022
- Pages: 123
- Category: Healthcare & Pharmaceuticals
North America organ transplant diagnostics market is projected to grow by 8.1% annually in the forecast period and reach $2,227.2 million by 2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced devices, and the surging investment and expenditure in healthcare and diagnostics.
Highlighted with 31 tables and 58 figures, this 123-page report “North America Organ Transplant Diagnostics Market 2022-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America organ transplant diagnostics market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2022 and provides forecast from 2022 till 2031 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America organ transplant diagnostics market in every aspect of the classification from perspectives of Offering, Transplant, Application, Technology, End User, and Country.
Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Instruments
• Test Kits & Consumables
o Kits & Assays
o Consumables
• Software & Services
Based on Transplant, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Solid Organ Transplant
o Kidney
o Liver
o Heart
o Lung
o Pancreas
o Kidney-Pancreas
o Other Solid Organ Transplants
• Stem Cell Transplant
• Soft Tissue Transplant
By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Diagnostics
o Donor Testing
o Recipient Testing
• Translational Research
By Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Molecular Technologies
o PCR
o Sequencing
o Other Molecular Technologies
• Serology
• Flow Cytometry
• Other Technologies
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
• Hospitals and Transplant Centers
• Reference Laboratories
• Academic and Research Institutions
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of national markets by Offering, Transplant and Technology over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories Inc.
ARUP Laboratories
BAG Health Care GmbH
Becton Dickinson and Company
bioMérieux S.A.
Bio-Rad Laboratories, Inc.
CareDx, Inc.
Eurofins Scientific
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Immucor, Inc.
Laboratory Corporation of America Holdings
Novacyt Group
Omixon Ltd.
OPKO Health
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 33
2.4 Emerging Opportunities and Market Trends 36
2.5 Porter’s Fiver Forces Analysis 40
3 Segmentation of North America Market by Offering 44
3.1 Market Overview by Offering 44
3.2 Instruments 46
3.3 Test Kits & Consumables 48
3.3.1 Kits & Assays 49
3.3.2 Consumables 51
3.4 Software & Services 53
4 Segmentation of North America Market by Transplant 55
4.1 Market Overview by Transplant 55
4.2 Solid Organ Transplant 57
4.2.1 Kidney 59
4.2.2 Liver 60
4.2.3 Heart 61
4.2.4 Lung 62
4.2.5 Pancreas 63
4.2.6 Kidney-Pancreas 64
4.2.7 Other Solid Organ Transplants 65
4.3 Stem Cell Transplant 66
4.4 Soft Tissue Transplant 67
5 Segmentation of North America Market by Application 68
5.1 Market Overview by Application 68
5.2 Diagnostics 70
5.2.1 Donor Testing 71
5.2.2 Recipient Testing 72
5.3 Translational Research 73
6 Segmentation of North America Market by Technology 74
6.1 Market Overview by Technology 74
6.2 Molecular Technologies 76
6.2.1 PCR 78
6.2.2 Sequencing 79
6.2.3 Other Molecular Technologies 80
6.3 Serology 81
6.4 Flow Cytometry 82
6.5 Other Technologies 83
7 Segmentation of North America Market by End User 84
7.1 Market Overview by End User 84
7.2 Hospitals and Transplant Centers 86
7.3 Reference Laboratories 87
7.4 Academic and Research Institutions 88
7.5 Other End Users 89
8 North America Market 2021-2031 by Country 90
8.1 Overview of North America Market 90
8.2 U.S. 93
8.3 Canada 96
8.4 Mexico 98
9 Competitive Landscape 100
9.1 Overview of Key Vendors 100
9.2 New Product Launch, Partnership, Investment, and M&A 103
9.3 Company Profiles 104
Abbott Laboratories Inc. 104
ARUP Laboratories 106
BAG Health Care GmbH 107
Becton Dickinson and Company 108
bioMérieux S.A. 109
Bio-Rad Laboratories, Inc. 110
CareDx, Inc. 111
Eurofins Scientific 112
F. Hoffmann-La Roche Ltd. 113
Illumina, Inc. 114
Immucor, Inc. 115
Laboratory Corporation of America Holdings 116
Novacyt Group 117
Omixon Ltd. 118
OPKO Health 119
QIAGEN N.V. 120
Quest Diagnostics Incorporated 121
Thermo Fisher Scientific Inc. 122
RELATED REPORTS 123
List of Tables
Table 1. Snapshot of North America Organ Transplant Diagnostics Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. World Health Spending by Region, $ bn, 2013-2020 32
Table 5. Main Product Trends and Market Opportunities in North America Organ Transplant Diagnostics Market 36
Table 6. North America Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 44
Table 7. Main Platforms and Key Vendors 47
Table 8. North America Organ Transplant Diagnostics Market: Test Kits & Consumables by Type, 2021-2031, $ mn 48
Table 9. Main Kits & Assays and Key Vendors 50
Table 10. Main Consumables and Key Vendors 52
Table 11. Main Services and Key Vendors 54
Table 12. North America Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 55
Table 13. North America Organ Transplant Diagnostics Market: Solid Organ Transplant by Type, 2021-2031, $ mn 58
Table 14. North America Organ Transplant Diagnostics Market by Application, 2021-2031, $ mn 68
Table 15. North America Organ Transplant Diagnostics Market: Diagnostics by Type, 2021-2031, $ mn 70
Table 16. North America Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 74
Table 17. North America Organ Transplant Diagnostics Market: Molecular Technologies by Type, 2021-2031, $ mn 77
Table 18. North America Organ Transplant Diagnostics Market by End User, 2021-2031, $ mn 84
Table 19. North America Organ Transplant Diagnostics Market by Country, 2021-2031, $ mn 91
Table 20. U.S. Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 95
Table 21. U.S. Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 95
Table 22. U.S. Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 95
Table 23. Canada Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 97
Table 24. Canada Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 97
Table 25. Canada Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 97
Table 26. Mexico Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 99
Table 27. Mexico Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 99
Table 28. Mexico Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 99
Table 29. Abbott Laboratories Inc.: Company Snapshot 104
Table 30. Abbott Laboratories Inc.: Business Segmentation 105
Table 31. Abbott Laboratories Inc.: Product Portfolio 105
List of Figures
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. North America Organ Transplant Diagnostics Market, 2021-2031, $ mn 20
Figure 5. Impact of COVID-19 on Business 25
Figure 6. Primary Drivers and Impact Factors of North America Organ Transplant Diagnostics Market 27
Figure 7. Leading Causes of Death in the World, 2019-2020, million 30
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 31
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 31
Figure 10. Primary Restraints and Impact Factors of North America Organ Transplant Diagnostics Market 33
Figure 11. Investment Opportunity Analysis 37
Figure 12. Porter’s Fiver Forces Analysis of North America Organ Transplant Diagnostics Market 40
Figure 13. Breakdown of North America Organ Transplant Diagnostics Market by Offering, 2021-2031, % of Revenue 45
Figure 14. North America Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%) 45
Figure 15. North America Organ Transplant Diagnostics Market by Offering: Instruments, 2021-2031, $ mn 46
Figure 16. North America Organ Transplant Diagnostics Market by Offering: Test Kits & Consumables, 2021-2031, $ mn 48
Figure 17. North America Organ Transplant Diagnostics Market by Test Kits & Consumables: Kits & Assays, 2021-2031, $ mn 49
Figure 18. North America Organ Transplant Diagnostics Market by Test Kits & Consumables: Consumables, 2021-2031, $ mn 51
Figure 19. North America Organ Transplant Diagnostics Market by Offering: Software & Services, 2021-2031, $ mn 53
Figure 20. Breakdown of North America Organ Transplant Diagnostics Market by Transplant, 2021-2031, % of Sales Revenue 56
Figure 21. North America Addressable Market Cap in 2022-2031 by Transplant, Value ($ mn) and Share (%) 56
Figure 22. North America Organ Transplant Diagnostics Market by Transplant: Solid Organ Transplant, 2021-2031, $ mn 57
Figure 23. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Kidney, 2021-2031, $ mn 59
Figure 24. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Liver, 2021-2031, $ mn 60
Figure 25. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Heart, 2021-2031, $ mn 61
Figure 26. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Lung, 2021-2031, $ mn 62
Figure 27. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Pancreas, 2021-2031, $ mn 63
Figure 28. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Kidney-Pancreas, 2021-2031, $ mn 64
Figure 29. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Other Solid Organ Transplants, 2021-2031, $ mn 65
Figure 30. North America Organ Transplant Diagnostics Market by Transplant: Stem Cell Transplant, 2021-2031, $ mn 66
Figure 31. North America Organ Transplant Diagnostics Market by Transplant: Soft Tissue Transplant, 2021-2031, $ mn 67
Figure 32. Breakdown of North America Organ Transplant Diagnostics Market by Application, 2021-2031, % of Sales Revenue 69
Figure 33. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 69
Figure 34. North America Organ Transplant Diagnostics Market by Application: Diagnostics, 2021-2031, $ mn 70
Figure 35. North America Organ Transplant Diagnostics Market by Diagnostics: Donor Testing, 2021-2031, $ mn 71
Figure 36. North America Organ Transplant Diagnostics Market by Diagnostics: Recipient Testing, 2021-2031, $ mn 72
Figure 37. North America Organ Transplant Diagnostics Market by Application: Translational Research, 2021-2031, $ mn 73
Figure 38. Breakdown of North America Organ Transplant Diagnostics Market by Technology, 2021-2031, % of Revenue 75
Figure 39. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 75
Figure 40. North America Organ Transplant Diagnostics Market by Technology: Molecular Technologies, 2021-2031, $ mn 76
Figure 41. North America Organ Transplant Diagnostics Market by Molecular Technologies: PCR, 2021-2031, $ mn 78
Figure 42. North America Organ Transplant Diagnostics Market by Molecular Technologies: Sequencing, 2021-2031, $ mn 79
Figure 43. North America Organ Transplant Diagnostics Market by Molecular Technologies: Other Molecular Technologies, 2021-2031, $ mn 80
Figure 44. North America Organ Transplant Diagnostics Market by Technology: Serology, 2021-2031, $ mn 81
Figure 45. North America Organ Transplant Diagnostics Market by Technology: Flow Cytometry, 2021-2031, $ mn 82
Figure 46. North America Organ Transplant Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn 83
Figure 47. Breakdown of North America Organ Transplant Diagnostics Market by End User, 2021-2031, % of Revenue 85
Figure 48. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 85
Figure 49. North America Organ Transplant Diagnostics Market by End User: Hospitals and Transplant Centers, 2021-2031, $ mn 86
Figure 50. North America Organ Transplant Diagnostics Market by End User: Reference Laboratories, 2021-2031, $ mn 87
Figure 51. North America Organ Transplant Diagnostics Market by End User: Academic and Research Institutions, 2021-2031, $ mn 88
Figure 52. North America Organ Transplant Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 89
Figure 53. Breakdown of North America Organ Transplant Diagnostics Market by Country, 2021 and 2031, % of Revenue 91
Figure 54. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 92
Figure 55. U.S. Organ Transplant Diagnostics Market, 2021-2031, $ mn 94
Figure 56. Canada Organ Transplant Diagnostics Market, 2021-2031, $ mn 96
Figure 57. Organ Transplant Diagnostics Market in Mexico, 2021-2031, $ mn 98
Figure 58. Growth Stage of North America Organ Transplant Diagnostics Industry over the Forecast Period 100
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
